Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib.
Woyach JA, Jones D, Jurczak W, Robak T, Illés Á, Kater AP, Ghia P, Byrd JC, Seymour JF, Long S, Mohamed N, Benrashid S, Lai TH, De Jesus G, Lai R, de Bruin G, Rule S, Munugalavadla V.
Woyach JA, et al. Among authors: long s.
Blood. 2024 Sep 5;144(10):1061-1068. doi: 10.1182/blood.2023023659.
Blood. 2024.
PMID: 38754046
Free PMC article.
Clinical Trial.